MYCN and neuroblastoma: In contrast, low gene and protein expression levels persisted in the 6 remaining post-therapy specimens (6 stage 4 NB; 3/6 MYCN amplified and 1p36 deleted tumors) (Figure 4A and 4C; cases #7-12).